Janux Therapeutics Inc

JANX NASDAQ Santé & Biotech États-Unis US47103J1051
14.21 $
2.38 %

Janux Therapeutics Inc se spécialise dans le développement de thérapies innovantes en immuno-oncologie pour traiter les cancers.

Performance & Momentum

6 Months 1.21 %
1 Year 37.46 %
3 Years 15.06 %
5 Years 27.79 %

Similar stocks to Janux Therapeutics Inc

Anantys Community

Be the first to share your analysis on Janux Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases